Objective: To evaluate over 108 weeks the effect of phentermine and topiramate extended release (PHEN/TPM ER) treatment on progression to type 2 diabetes and/or cardiometabolic disease in subjects ...

Phentermine-topiramate (Qsymia®). This combination medication contains phentermine (a stimulant that suppresses appetite) and topiramate, an anticonvulsant that may help with weight loss by ...

Efforts to develop new anti-obesity drugs will face a critical test when two of the three therapies currently under consideration by the US FDA for regulatory ...